F. James Primus
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Immunology top 2%
- Immunotherapy and Immune Responses
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 39
- Radiopharmaceutical Chemistry and Applications 35
- Immunology 26
- Immunotherapy and Immune Responses 21
- T-cell and B-cell Immunology 6
- Co-authors
- David M. Goldenberg (23 shared papers)Robert M. Sharkey (11 shared papers)Sidney Bennett (4 shared papers)D M Goldenberg (8 shared papers)Frank H. DeLand (4 shared papers)John R. van Nagell (3 shared papers)Norman Estes (1 shared paper)Paolo De Simone (1 shared paper)
- Journals
- International Journal of Cancer (7 papers)Cancer (5 papers)JNCI Journal of the National Cancer Institute (4 papers)Cancer Immunology Immunotherapy (4 papers)Proceedings of the National Academy of Sciences (4 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
F. James Primus
77 papers receiving 3.3k citations
F. James Primus's Hit Papers
Peers
Comparison fields: 5 of 113
- Radiology, Nuclear Medicine and Imaging 2.1k
- Immunology 936
- Oncology 1.1k
- Biotechnology 208
- Molecular Biology 1.2k
Countries citing papers authored by F. James Primus
This map shows the geographic impact of F. James Primus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. James Primus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. James Primus more than expected).
Fields of papers citing papers by F. James Primus
This network shows the impact of papers produced by F. James Primus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. James Primus. The network helps show where F. James Primus may publish in the future.
Co-authors
The 25 scholars most cited alongside F. James Primus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning Hit paper breakdown → | 1978 | 544 |
| 2 | Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. | 1980 | 207 |
| 3 | 1976 | 193 | |
| 4 | 1978 | 134 | |
| 5 | Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy. | 1998 | 133 |
| 6 | Immunological heterogeneity of carcinoembryonic antigen: antigenic determinants on carcinoembryonic antigen distinguished by monoclonal antibodies. | 1983 | 125 |
| 7 | 1980 | 98 | |
| 8 | Localization of human GW-39 tumors in hamsters by radiolabeled heterospecific antibody to carcinoembryonic antigen. | 1973 | 96 |
| 9 | 1988 | 86 | |
| 10 | 2001 | 79 | |
| 11 | 2005 | 79 | |
| 12 | 2006 | 74 | |
| 13 | Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein. | 2000 | 70 |
| 14 | 2007 | 65 | |
| 15 | Circulating immune complexes in cancer patients receiving goat radiolocalizing antibodies to carcinoembryonic antigen. | 1980 | 61 |
| 16 | ABH and Lewis blood group expression in colorectal carcinoma. | 1987 | 57 |
| 17 | Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen. | 1987 | 54 |
| 18 | Localization of GW-39 human tumors in hamsters by affinity-purified antibody to carcinoembryonic antigen. | 1977 | 49 |
| 19 | 1989 | 47 | |
| 20 | 1982 | 47 |
About F. James Primus
F. James Primus is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, having authored 77 papers that have together received 3.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (39 papers), Radiopharmaceutical Chemistry and Applications (35 papers), Immunotherapy and Immune Responses (21 papers), Glycosylation and Glycoproteins Research (12 papers), CAR-T cell therapy research (8 papers), Medical Imaging and Pathology Studies (7 papers), Virus-based gene therapy research (6 papers) and T-cell and B-cell Immunology (6 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (2.1k citations), Immunology (936 citations), Oncology (1.1k citations), Biotechnology (208 citations) and Molecular Biology (1.2k citations). F. James Primus has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include David M. Goldenberg, Robert M. Sharkey, Sidney Bennett, D M Goldenberg, Frank H. DeLand, John R. van Nagell, Norman Estes, Paolo De Simone, F. H. DeLand and Jean F. Simpson. Their work appears in journals such as International Journal of Cancer, Cancer, JNCI Journal of the National Cancer Institute, Cancer Immunology Immunotherapy and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.